Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
123.60
-2.58 (-2.04%)
Sep 5, 2025, 3:26 PM IST
NSE:LOTUSEYE Revenue
Lotus Eye Hospital and Institute had revenue of 135.17M INR in the quarter ending June 30, 2025, with 4.86% growth. This brings the company's revenue in the last twelve months to 501.89M, up 3.41% year-over-year. In the fiscal year ending March 31, 2025, Lotus Eye Hospital and Institute had annual revenue of 495.63M with 2.81% growth.
Revenue (ttm)
501.89M
Revenue Growth
+3.41%
P/S Ratio
5.04
Revenue / Employee
1.44M
Employees
348
Market Cap
2.53B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 495.63M | 13.53M | 2.81% |
Mar 31, 2024 | 482.10M | 11.66M | 2.48% |
Mar 31, 2023 | 470.44M | 81.34M | 20.90% |
Mar 31, 2022 | 389.10M | 65.51M | 20.24% |
Mar 31, 2021 | 323.59M | -81.94M | -20.21% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 537.77B |
Divi's Laboratories | 96.52B |
Cipla | 274.80B |
Apollo Hospitals Enterprise | 225.51B |
Mankind Pharma | 129.10B |
Zydus Lifesciences | 236.08B |
Fortis Healthcare | 80.94B |
Alkem Laboratories | 133.04B |